To ascertain the role of PSAT1 in liver cancer progression, tissue samples and datasets were analyzed and we found that the protein or mRNA levels of PSAT1 were negatively correlated with the overall survival rate of HCC patients (Fig. 2a, b). Here, PSAT1 is linked to hepatocellular carcinoma.